PTSD Trial, Recruiting (NCT06776523)

PTSD Trial, Recruiting NCT06776523 Sponsor: University of Zurich Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06776523 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are refugees or asylum seekers aged 16 or older
People who are living in one of the participating Swiss towns or transitional asylum centres where the PM+ program is being offered
People who speak at least one of these 12 languages: German, English, French, Arabic, Farsi, Kurdish, Tigrinya, Turkish, Ukrainian, Russian, Tamil, or Pashto
People who score 20 or higher on a short questionnaire about general mental and emotional stress experienced over the past 30 days (this score indicates moderate to high levels of psychological distress)

Who may not be able to join:

People with significant difficulties related to memory, thinking, or neurological conditions, as assessed using specific tools developed by the World Health Organization (WHO)
People with serious current medical conditions or severe mental health disorders — such as psychosis or substance abuse disorders — as assessed using WHO tools
People who are currently at high risk of suicide, as measured by two specific assessment questionnaires used in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Naser Morina, PD Dr., Klinik für Konsiliarpsychiatrie und Psychosomatik

Phone: +41 44 255 5280

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06776523

Sponsor: University of Zurich

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: +41 44 255 5280

More information: https://clinicaltrials.gov/study/NCT06776523

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are refugees or asylum seekers aged 16 or older
People who are living in one of the participating Swiss towns or transitional asylum centres where the PM+ program is being offered
People who speak at least one of these 12 languages: German, English, French, Arabic, Farsi, Kurdish, Tigrinya, Turkish, Ukrainian, Russian, Tamil, or Pashto
People who score 20 or higher on a short questionnaire about general mental and emotional stress experienced over the past 30 days (this score indicates moderate to high levels of psychological distress)

Who may not be able to join:

People with significant difficulties related to memory, thinking, or neurological conditions, as assessed using specific tools developed by the World Health Organization (WHO)
People with serious current medical conditions or severe mental health disorders — such as psychosis or substance abuse disorders — as assessed using WHO tools
People who are currently at high risk of suicide, as measured by two specific assessment questionnaires used in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Zurich

Registry

ClinicalTrials.gov

Start date

16 January 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Change in psychological distress

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov